[go: up one dir, main page]

WO2013038119A3 - Dispositif de stockage et de distribution de liquide pharmaceutique - Google Patents

Dispositif de stockage et de distribution de liquide pharmaceutique Download PDF

Info

Publication number
WO2013038119A3
WO2013038119A3 PCT/FR2012/052079 FR2012052079W WO2013038119A3 WO 2013038119 A3 WO2013038119 A3 WO 2013038119A3 FR 2012052079 W FR2012052079 W FR 2012052079W WO 2013038119 A3 WO2013038119 A3 WO 2013038119A3
Authority
WO
WIPO (PCT)
Prior art keywords
storing
liquid
dispensing pharmaceutical
pharmaceutical liquid
prostaglandin
Prior art date
Application number
PCT/FR2012/052079
Other languages
English (en)
Other versions
WO2013038119A2 (fr
Inventor
Thierry Rimlinger
Pascal Dugand
Nolwenn Stephan
Original Assignee
Rexam Healthcare La Verpilliere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rexam Healthcare La Verpilliere filed Critical Rexam Healthcare La Verpilliere
Publication of WO2013038119A2 publication Critical patent/WO2013038119A2/fr
Publication of WO2013038119A3 publication Critical patent/WO2013038119A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/04—Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D171/00—Coating compositions based on polyethers obtained by reactions forming an ether link in the main chain; Coating compositions based on derivatives of such polymers
    • C09D171/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/04—Polysiloxanes
    • C09D183/08—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen, and oxygen
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
    • C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
    • C08G77/24—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen halogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/80—Siloxanes having aromatic substituents, e.g. phenyl side groups
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La présente invention concerne un dispositif de stockage et de distribution de liquide pharmaceutique tel que du liquide ophtalmique. Plus particulièrement, le liquide ophtalmique comprend, en tant que principe actif, au moins une prostaglandine, au moins un analogue d'une prostaglandine ou au moins une protéine, notamment pour le traitement du glaucome. Le dispositif selon l'invention comprend, sur au moins une partie d'une surface interne du dispositif, un revêtement réduisant la sorption du liquide sur la surface revêtue, ce revêtement étant hydrophobe.
PCT/FR2012/052079 2011-09-16 2012-09-17 Dispositif de stockage et de distribution de liquide WO2013038119A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1158281 2011-09-16
FR1158281 2011-09-16

Publications (2)

Publication Number Publication Date
WO2013038119A2 WO2013038119A2 (fr) 2013-03-21
WO2013038119A3 true WO2013038119A3 (fr) 2015-02-19

Family

ID=47883849

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2012/052079 WO2013038119A2 (fr) 2011-09-16 2012-09-17 Dispositif de stockage et de distribution de liquide

Country Status (1)

Country Link
WO (1) WO2013038119A2 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997423A (en) * 1986-10-15 1991-03-05 Daikyo Gomu Seiko Ltd. Laminated sliding stopper for a syringe
JPH05132065A (ja) * 1991-11-05 1993-05-28 Nichiden Rika Glass Hanbai Kk 表面処理されたガラス瓶
US20030134060A1 (en) * 1999-05-07 2003-07-17 Marten Walther Glass container for medicinal purposes
US20040071906A1 (en) * 2000-12-13 2004-04-15 Derek Brewis Surface modification process
US20040199138A1 (en) * 2001-07-21 2004-10-07 Mcbay William Edward Storage of liquid compositions
US20060200084A1 (en) * 2004-09-28 2006-09-07 Akira Ito Syringe
US20070287954A1 (en) * 2006-03-30 2007-12-13 Becton, Dickinson And Company Coating System, Articles and Assembly Using the Same and Methods of Reducing Sticktion
US20100044268A1 (en) * 2006-01-11 2010-02-25 Daniel Haines Pharmaceutical package having a multi-functional surface and a method of preparing a multi-functional surface on a pharmaceutical package

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997423A (en) * 1986-10-15 1991-03-05 Daikyo Gomu Seiko Ltd. Laminated sliding stopper for a syringe
JPH05132065A (ja) * 1991-11-05 1993-05-28 Nichiden Rika Glass Hanbai Kk 表面処理されたガラス瓶
US20030134060A1 (en) * 1999-05-07 2003-07-17 Marten Walther Glass container for medicinal purposes
US20040071906A1 (en) * 2000-12-13 2004-04-15 Derek Brewis Surface modification process
US20040199138A1 (en) * 2001-07-21 2004-10-07 Mcbay William Edward Storage of liquid compositions
US20060200084A1 (en) * 2004-09-28 2006-09-07 Akira Ito Syringe
US20100044268A1 (en) * 2006-01-11 2010-02-25 Daniel Haines Pharmaceutical package having a multi-functional surface and a method of preparing a multi-functional surface on a pharmaceutical package
US20070287954A1 (en) * 2006-03-30 2007-12-13 Becton, Dickinson And Company Coating System, Articles and Assembly Using the Same and Methods of Reducing Sticktion

Also Published As

Publication number Publication date
WO2013038119A2 (fr) 2013-03-21

Similar Documents

Publication Publication Date Title
EA201301303A1 (ru) Система, включающая распылитель и упаковку
EP3998923A4 (fr) Dispositif de cartouche de pulvérisation
EP3836997A4 (fr) Plate-forme de dosage de vapeur pour cartouches de vaporisation
EP3270992A4 (fr) Vaporisateur pour vaporiser un ingrédient actif
HK1198631A1 (en) Prevention and treatment of ocular conditions
WO2015106269A8 (fr) Formulations d'insuline à action rapide et systèmes d'administration pharmaceutique
EP3613511A4 (fr) Pulvérisateur de liquide de type à gâchette
WO2014085307A3 (fr) Dépôt par rotation combinatoire
WO2012012772A3 (fr) Hydrogels à élution de médicaments destinés à être administrés par cathéter
EP3840733A4 (fr) Oligonucléotides antisens ciblant scn2a pour le traitement d'encéphalopathies scn1a
EP3137481A4 (fr) Systèmes auto-assemblés adhérant à la membrane pour le traitement de troubles oculaires
PL3583098T3 (pl) Związki hydrofilowe dla urządzeń aktywnych optycznie
EP3706729A4 (fr) Composés fusogènes pour l'administration de molécules biologiquement actives
EP3962309A4 (fr) Dispositif de vaporisation de liquide
WO2014096854A3 (fr) Dispositifs ophtalmiques pour administrer des agents à effet bénéfique
EP3863703A4 (fr) Inhalateur de brume à ultrasons
EP3266317A4 (fr) Composition pour prévenir, améliorer ou traiter des troubles neurologiques, contenant un peptide d'osmotine comme principe actif
WO2012163827A3 (fr) Préparation ophtalmique contenant un analogue de pgf2alpha
EP4037740A4 (fr) Nébuliseur acoustique pour la livraison d'agents actifs
EP4031218A4 (fr) Nébulisateur à ultrasons
EP3668991A4 (fr) Nanosupports pour l'administration de principes actifs
EP3978144A4 (fr) Dispositif de dépôt de gouttelette
WO2013038120A3 (fr) Dispositif de stockage et de distribution de liquide
WO2007107605A3 (fr) Procede destine au traitement d'une surface hydrophobe par une phase aqueuse
WO2013038119A3 (fr) Dispositif de stockage et de distribution de liquide pharmaceutique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12831784

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12831784

Country of ref document: EP

Kind code of ref document: A2